Good Business Lab
Bengaluru, Karnataka, 560102, India
NCT Number: NCT04629820
The investigators will conduct a randomized-controlled trial. The participants will be textile workers aged 35 years and above with uncorrected presbyopia who are employed by a single Indian garment manufacturer - employed by Shahi Exports Private Limited, Karnataka, India - at facilities equipped to measure individual productivity. PROSPER II will assess the impact of free reading glasses on productivity for workers in a textile factory.
Looking for future studies?
Notify Me35 year and older
All sexes
Interventional
Not applicable
Bengaluru, Karnataka, 560102, India
Globally, 3 billion people do not have the eyeglasses they need to earn, learn, travel safely in traffic and participate in civic life. Among these, 1.1 billion people lack a simple pair of reading glasses to correct impaired near vision, called presbyopia. Presbyopia, the essentially universal decline in unaided near vision that occurs with aging, is the world's most common cause of vision impairment. Loss of accommodation (ability to change focus from distance to near) due to presbyopia can begin as early as age 30 years, commonly becomes functionally apparent by 40, and is essentially complete by 55, meaning that presbyopia is most common at the height of the working years.
Study Plan: This is a randomized trial designed to assess the impact of free spectacles on workplace productivity among Indian textile workers.
Research question: Will providing free glasses to presbyopic Indian textile workers increase work productivity?
Design: Investigator-masked, multi-center randomized controlled trial
Rationale: Although presbyopia is safely, effectively and inexpensively treated with glasses, rates of optical correction in LMICs are as low as 10%. The global productivity loss due to uncorrected presbyopia has been estimated to exceed US$25 billion, and presbyopia is shown to be associated with significant impairment in activities of daily living. Few trials have been published which address the question of whether healthcare interventions can improve work performance as well as workplace retention, especially among persons over the age of 40 in low and middle-income countries (LMICs). The largest reported effect sizes among such trials was the PROSPER trial, which showed that providing inexpensive near vision glasses increased the daily weight of tea picked among presbyopic, mostly-female Indian agricultural workers by more than 5 kg (21.6%) compared to those in the control group. Costs were low, over half of pickers aged >= 40 years met criteria to receive glasses, and wearing compliance reached nearly 90%. There is interest to understand if these results from the agricultural setting can be extended to other financially-important sectors.
Methods : The investigators will enrol 800 textile workers aged 35 years and above with uncorrected presbyopia who are employed by Shahi Exports Private Limited in Karnataka, India. Eligible participants will be randomly assigned to Intervention and Control Groups (1:1). Intervention group participants will receive free reading glasses within a week of undergoing a vision screening at the factory. Control group participants will receive reading glasses at the end of the assessment period (three months after vision screening).
The main outcome 3 months later will be work productivity; secondary outcomes are change in skill grade, change in monthly wage, participants' adherence with spectacle wear, self-assessed self-efficacy score and change of quality of life scores. The intervention cost-effectiveness will be studied.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention group workers receive free glasses within one week of undergoing vision assessment (September 2021). The assessment period will be three months
Other names: Near eyeglasses, Reading glasses
Time frame: Over the three month follow-up period from enrolment to study completion
Efficiency is calculated as the proportion of target production realized by a worker per unit time
Time frame: Between baseline and study end three months later
Skill grade ranges from A triple star (highest) to A double star, A star, A, B, and C + (lowest)
Time frame: Between baseline and study end three months later
Monthly wage (Factory administrative data)
Time frame: Between baseline and study end three months later
measured weekly by enumerator's unannounced observations of the presence of spectacles worn on the participant's face.
Time frame: Between baseline and conclusion of the study three months later
Self-assessed self-efficacy scores measured using the Cantril's Ladder, with the best possible score being a 10, and the worst being a 0 (Cantril's Ladder)
Time frame: Between baseline and conclusion of the study three months later
Quality of life scores measured using the Andhra Pradesh Eye Disease Study (APEDS) Visual Function Questionnaire (VFQ), with a 5-point Likert scale: 1=No difficulty, 2=Little difficulty, 3=Moderate difficulty, 4=Great difficulty but still can manage, 5=Cannot manage. A highest score represents great difficulty in vision function. Minimum score = 16; Maximum score = 80.
Time frame: Between baseline and study end three months later
Full programme costs per individual identified and corrected with presbyopia. Programme costs include costs incurred in screening test, glasses / replacement and direct/indirect costs for facilitating work-based site. Benefit will be measured using work productivity. We will report cost effectiveness distinguishing between study costs and program costs
Queen's University, Belfast
Other
Effects of Near Vision Spectacle Correction on Work Productivity Among Textile Factory Workers in India
Acronym: PROSPERII
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04654013
Eye Diseases, Presbyopia
Bengaluru, Karantaka, India
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial DetailsNCT05656027
Eye Diseases, Myopia
Chandler, Arizona, United States
View Trial DetailsNCT05753189
Eye Diseases, Myopia
Dothan, Alabama, United States
View Trial Details